CIK 0001035354
- Non-accelerated filer
- Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841368850
- Phone
- +1 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- 4 Open-market buy Director bought 21,875 shares at $0.90 ($7,000)
- 4 Open-market buy Director bought 9,375 shares at $0.90 ($3,000)
- 4 Open-market buy Director bought 3,125 shares at $0.90 ($1,000)
- 4 Open-market buy Director bought 42,188 shares at $0.90 ($13,500)
- 4 Open-market buy Director bought 42,188 shares at $0.90 ($13,500)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 4,800 shares at an average $0.48 ($2,287)
- 4 Open-market buy Director bought 12,200 shares at an average $0.39 ($4,698)
- 4 Open-market buy Director bought 10,000 shares at $0.37 ($3,700)
- 4 Open-market buy Director bought 11,200 shares at an average $0.39 ($4,331)
- 4 Open-market buy Director bought 10,000 shares at $0.36 ($3,600)
- 4 Open-market buy Director bought 12,500 shares at an average $0.38 ($4,725)
- 4 Open-market buy Director bought 8,500 shares at an average $0.40 ($3,360)
- 4 Open-market buy Director bought 7,000 shares at an average $0.38 ($2,686)
- 4 Open-market buy Director bought 9,000 shares at an average $0.40 ($3,580)
- 4 Open-market buy Director bought 15,000 shares at an average $0.44 ($6,657)
- 4 Open-market buy Director bought 5,000 shares at an average $0.41 ($2,075)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 22 of 29 · 574 filings